National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
Authors:
- Niccolò GoriNGNiccolò Gori
- Andrea ChiricozziACAndrea Chiricozzi
- Franco MarsiliFMFranco Marsili
- Silvia Mariel FerrucciSilvia Mariel Ferrucci
- Paolo AmerioPAPaolo Amerio
- Vincenzo BattarraVBVincenzo Battarra
- Salvatore CampitielloSCSalvatore Campitiello
- Antonio CastelliACAntonio Castelli
- Maurizio CongedoMCMaurizio Congedo
- Monica CorazzaMCMonica Corazza
- Antonio CristaudoACAntonio Cristaudo
- Gabriella FabbrociniGFGabriella Fabbrocini
Open Access
- 2 September 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 5204
Abstract
Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.Keywords
This publication has 28 references indexed in Scilit:
- Atopic Dermatitis in Adults: A Diagnostic ChallengeJournal of Investigational Allergology and Clinical Immunology, 2017
- Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic DermatitisChinese Medical Journal, 2016
- Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysisBritish Journal of Dermatology, 2016
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic DermatitisNew England Journal of Medicine, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Adult onset atopic dermatitis: Under-recognized or under-reported?Indian Dermatology Online Journal, 2013
- Atopic dermatitis in older patients: particular pointsJournal of the European Academy of Dermatology and Venereology, 2010
- The Relationship Between Serum Levels of Total IgE, IL‐18, IL‐12, IFN‐γ and Disease Severity in Children With Atopic DermatitisMediators of Inflammation, 2006
- Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis indexMediators of Inflammation, 2003
- Sleep Fragmentation in Children With Atopic DermatitisArchives of Pediatrics & Adolescent Medicine, 1999